Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.
Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.
Reuters NewMedia - Saturday, November 28, 1992
The rate of premature deaths among whites, both men and women, decreased during the decade between 1979 and 1989, but the rate increased for black men and black women, the Centers for Disease Control said.
The Atlanta-based CDC said the rate of premature deaths had declined for blacks between 1979 and 1984, but began to rise sharply in the mid-1980s.
"This report indicates an increasing disparity in early death between whites and blacks in recent years," the agency said.
"The greatest disparities in rates are for homicide, HIV infection and cerebrovascular disease."
The agency attributed differences in socioeconomic status and access to health care as the factors most responsible for the disparity between blacks and whites.
The CDC uses a complex mathematical formula called "years of potential life lost" to measure premature death rates. Under this formula, the agency attempts to measure all deaths occurring before the age of 65.
On the scale of "years of potential life lost," a person who dies at age 60 is said to have lost five potential years of life, while one who dies at age 30 is said to have lost 35 years of potential life.
The toll of murder is particularly striking among blacks and whites as measured on this scale. For every 1,000 white males, only 2.8 years of potential life was lost in 1989. For black males, the number was 22.5.
Among black females, the murder rate in 1989 was nearly five times higher than for white females -- 4.7 for blacks versus 1.0 for whites.
The years of potential life lost to AIDS was only 0.3 per 1,000 among white females. But among black females, the rate was 2.8 per 1,000. The rate for black males was 11.1 per 1,000 compared to 3.9 for white males.
Copyright © 1992 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .